CHMP5 and COVID-19: The recent discovery of the blood–brain barrier-penetrating SARS-CoV-2 spike protein9 offers a new possibility that the SARS-CoV-2-derived spike protein causes neurological or psychiatric symptoms observed in the COVID-19 survivors, which we tested in this study.